Hyperlipidemia

FDA Approves Pitavastatin for Hyperlipidemia, Mixed Dyslipidemia

FDA Approves Pitavastatin for Hyperlipidemia, Mixed Dyslipidemia

By

Multiple clinical studies have examined the efficacy of pitavastatin.

Fenofibrate May Mimic Cannabinoid Receptor Stimulation

Fenofibrate May Mimic Cannabinoid Receptor Stimulation

By

Researchers have discovered that a common medication indicated for the treatment of high cholesterol may stimulate the same peroxisome proliferator-activated receptors (PPARs) as cannabinoids, which could lead to a new class of cannabis-like drugs to treat a range of conditions.

Sign Up for Free e-Newsletters



CME Focus